Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Clear all

282 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20014
20021
20032
20045
20052
20065
20074
20085
200912
20106
201111
201212
20137
20149
20157
201612
201715
201824
201918
202012
20217
202214
20239
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed282

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)24
Novo Nordisk A/S19
National Human Genome Research Institute (NHGRI)8
BioMarin Pharmaceutical7
Regeneron Pharmaceuticals7
FDA Office of Orphan Products Development6
National Cancer Institute (NCI)5
National Heart, Lung, and Blood Institute (NHLBI)5
Swedish Orphan Biovitrum5
Vertex Pharmaceuticals Incorporated5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn282
Rare Diseases58
Hematologic Diseases36
Respiratory Tract Diseases29
Cystic Fibrosis27
Metabolic Diseases26
Metabolism, Inborn Errors24
Nervous System Diseases22
Anemia, Sickle Cell18
Musculoskeletal Diseases18

Trials

Showing 26 to 50 of 282. Each trial links to its page on Pharma Observatory.

182 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.